AlpalifeBio
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $9.8M
Investors
- 4
About AlpalifeBio
Founded in 2016 and based in Shenzhen, China, AlpalifeBio focuses on developing and providing nanobody technologies., Galaxy Capital and Nanling Fund. AlpalifeBio specializes in the development and provision of nanobody technologies, focusing specifically on discovering and producing nanobodies that target G protein-coupled receptors (GPCRs). The company offers a variety of research products, including tagged nanobody beads, recombinant nanobodies, and protein purification materials, essential for various biomedical research applications. Utilizing advanced protein expression systems such as insect, mammalian, yeast, and E. coli cells, AlpalifeBio generates high-quality proteins for pharmaceutical development, serving a global clientele that includes academic institutions, pharmaceutical companies, and biotechnology firms. The company generates revenue mainly through the sale of its proprietary nanobody products and Contract Research Organization (CRO) services. The company operates a B2B model, engaging clients in purchasing agreements for research reagents and services, including multi-year contracts for ongoing research support related to nanobody-based therapies. Revenue is further enhanced through strategic partnerships and collaborations with other firms.
Who invested in AlpalifeBio
4 investors across 1 round
See all investors in AlpalifeBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 9, 2025
Amount
$9.8M
Investors
Questions about AlpalifeBio
Who invested in AlpalifeBio?
AlpalifeBio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AlpalifeBio raised?
AlpalifeBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AlpalifeBio last raise money?
AlpalifeBio's most recent round on record is a Series A, in Sep 2025.
What does AlpalifeBio do?
Founded in 2016 and based in Shenzhen, China, AlpalifeBio focuses on developing and providing nanobody technologies.
Where is AlpalifeBio headquartered?
AlpalifeBio is headquartered in Shenzhen, China.
Which VCs invest in companies like AlpalifeBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at AlpalifeBio's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like AlpalifeBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.